Clume Health review
Both molecules carry one monthly figure, and the lower advertised figure requires a twelve-week prepaid term.
The verdict
Clume Health publishes $259 a month for both molecules. It is printed as a starting figure. A lower figure of $200 appears on the pages and requires a twelve-week prepaid term.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- From $259/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Clume Health sells both molecules by injection. Two lines carry figures. Both carry the same figure.
Who writes the prescription, and what do they see?
A prescription precedes shipping. The pages state prices and terms rather than clinician detail. The intake is not documented.
Two things matter here. Both molecules carry one figure. And the attractive figure carries a twelve-week prepay. Neither is hidden; the prepay is easy to miss beside the lower number.
What happens when the dose goes up?
Nothing is published about what either figure does at a higher dose. $259 is a starting figure. Ask what it becomes at your dose before the second month.
What the price includes
$259 is the current monthly figure on both lines. Six months at it is $1,554. The $200 figure needs twelve weeks paid up front. Confirm the figure on the seller's own page before ordering.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: Both molecules at the same figure
- Strength: The prepay condition is stated
- Limitation: $259 is printed as a starting figure
- Limitation: The low figure needs twelve weeks prepaid
- Limitation: No dose behavior is published
- Limitation: No state coverage list is recorded
What the evidence says about this kind of treatment
The assessment above is about Clume Health. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who will confirm the figure on the day before ordering.
- Wrong for
- A reader relying on a quote more than a few weeks old.
The evidence behind what Clume Health prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Clume Health compares
| Seller | Who it suits | Go |
|---|---|---|
 AVARA Rx | A reader who wants the consult inside the price, and who plans against the standing rate rather than a code that can be withdrawn. | See AVARA Rx → |
 Embody | Readers who will establish the care arrangements and recurring agreement before enrollment | See Embody → |
 ARSYNL Rx | Readers who want both molecules priced on one page and will confirm the figure on the day | See ARSYNL Rx → |
More GLP-1 telehealth sellers reviews: Metabolic RxMetabolyzMixx Health & WellnessModern AgeNovera MDNuform Health
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- What is the current price?
- $259 a month on both lines, printed as a starting figure.
- How do I get $200?
- That figure requires a twelve-week prepaid term. The monthly rate is $259.
- Does the price change with the dose?
- Not published. Confirm the rate at your dose on the seller's own page before acting.
- Is Clume Health expensive compared with other GLP-1 telehealth sellers?
- Clume Health publishes a starting figure of $259/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Clume Health above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.